Ep. 55: Public Health Insights with Dr. Tiffany Gray (GWU Adjunct Professor)

Health Unchained

Ep. 55: Public Health Insights with Dr. Tiffany Gray (GWU Adjunct Professor)

Ray's Upcoming Events Blockchain and Digital tran…
February 1, 2020

Ep. 55: Public Health Insights with Dr. Tiffany Gray (GWU Adjunct Professor)

Ray’s Upcoming Events
Blockchain and Digital transformation in Health 2020 – Austin, TX – Feb. 26

Health Unchained Links
Bert’s Blockchain and Healthcare Weekly Newsletter:

Show Notes

Guest Website:
Dr. Tiffany Gray, holds a Doctorate in Public Health in Health Behavior and a Master’s in Public Health in Maternal and Child Health, from the Milken Institute School of Public Health at the George Washington University in Washington, DC. She also serves as the co-chair and adviser for the global health and disaster relief subcommittee as part of the United Nations’ blockchain for impact and sustainable development initiative. We talked about a variety of public health issues and how blockchain could serve as a tool to improving access to care globally.

•Introduction of Dr. Tiffany Gray – academia, career, running marathons
•Smoking cessation efforts
•Researching Nicotine use among young adults and kids
•How did you first hear about blockchain technology?
•What are some examples of Public Health Initiatives using blockchain or plan to use some DLT?
•How can technology create better opportunities for addiction treatment?
•Can you describe the landscape of public investment for Mental health care in US/Global?
•Problems in healthcare data security/privacy/sharing
•Consulting Experience in private sector
•What would you ask healthcare/financial regulators to do/understand about this new distributed/decentralized economy?
•Favorite books, marathon running, and cooking during free time

News Corner
Welcome to the Health Unchained New Corner.
A new business network has been created based on an interoperability pilot program started from the FDA’s Drug Supply Chain Security Act (DSCSA). The original pilot participants included KPMG, Merck, Walmart, and IBM. This business network is called the Pharmaceutical Utility Network (or PhUN).
According to the IBM blog, this transformation of the compliance process allows innovators to focus on using the data now available to them to fuel the creation and deployment of new, cutting-edge applications onto the platform, leading to new business capabilities, business relationships and eventually business models.
PhUN is currently working with initial participants to explore five pharmaceutical industry problem areas:
•Regulatory compliance
•Cold chain efficiency
•Drug shortages
•Drug recalls
•Clinical trials

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

Four Authors Untangle When Dad Has Dementia Virtual Q&A on the changes and challenges a dementia diagnosis.